EVALUATION IN HYPERTENSIVE PATIENTS OF LABETALOL A NEW ALPHA ADRENERGIC AND BETA ADRENERGIC BLOCKING AGENT

dc.contributor.authorMIJANGOS LAZCANO, D
dc.date.accessioned2026-05-28T16:55:13Z
dc.date.issued1978
dc.description.paginacion435 - 441
dc.description.procedenciaLOC
dc.format.discursoArtículo
dc.format.extent7
dc.identifier.issn0185-2108
dc.identifier.urihttps://ahcm.cinvestav.mx/handle/ahcm/29969
dc.language.isoEspañol
dc.numero.secuencia29966
dc.publisherSECRETARIA SALUBRIDA ASIST,HOSP GEN,MEXICO CITY 11,MEXICO
dc.relation.ispartofseriesVol. 5 No. 5
dc.source.revistafuenteINVESTIGACION MEDICA INTERNACIONAL
dc.subjectEVALUATION, HYPERTENSIVE, PATIENTS, LABETALOL, ALPHA ADRENERGIC, BETA ADRENERGIC, BLOCKING AGENT
dc.subject.categoriaprincipalCIENCIAS MEDICAS
dc.subject.disciplinaFARMACOLOGIA
dc.subject.subdisciplinaFARMACOLOGIA EXPERIMENTAL
dc.titleEVALUATION IN HYPERTENSIVE PATIENTS OF LABETALOL A NEW ALPHA ADRENERGIC AND BETA ADRENERGIC BLOCKING AGENT
dc.title.alternativeINVEST MED INT

Files